Efficacy and the Safety of Granulocyte Colony-Stimulating Factor Treatment in Patients with Muscular Dystrophy: A Non-Randomized Clinical Trial

INTRODUCTION: The current standard treatment for patients with Duchenne muscular dystrophy (DMD) involves corticosteroids. Granulocyte colony-stimulating factor (G-CSF) induces the proliferation of satellite cells and myoblasts and, in turn, muscle regeneration. Beneficial effects of G-CSF were also...

Descripción completa

Detalles Bibliográficos
Autores principales: Sienkiewicz, Dorota, Kułak, Wojciech, Okurowska-Zawada, Bożena, Paszko-Patej, Grażyna, Wojtkowski, Janusz, Sochoń, Karolina, Kalinowska, Anna, Okulczyk, Kamila, Sienkiewicz, Jerzy, McEachern, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662550/
https://www.ncbi.nlm.nih.gov/pubmed/29123500
http://dx.doi.org/10.3389/fneur.2017.00566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662550/
https://www.ncbi.nlm.nih.gov/pubmed/29123500
http://dx.doi.org/10.3389/fneur.2017.00566

Ejemplares similares